BevacizumabIn First-Line Treatment of Advanced and/or Metastatic Renal Cell Carcinoma

被引：0
|
作者：
James E. Frampton
Gillian M. Keating
机构：
[1] Wolters Kluwer Health ¦ Adis,
[2] Wolters Kluwer Health,undefined
来源：
BioDrugs | 2008年 / 22卷
关键词：
Vascular Endothelial Growth Factor; Renal Cell Carcinoma; Bevacizumab; Sorafenib; Erlotinib;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
▴ Bevacizumab, an anti-vascular endothelial growth factor recombinant humanized monoclonal antibody, directly inhibits tumor angiogenesis and hence tumor growth.
引用
收藏
页码：113 / 120
页数：7
相关论文
共 50 条
  • [41] Cabozantinib as first-line treatment in advanced renal cell carcinoma: a profile of its use
    Lyseng-Williamson K.A.
    Drugs & Therapy Perspectives, 2018, 34 (10) : 457 - 465
  • [42] Advanced Renal Cell Carcinoma Cabozantinib is a recommended Treatment Option for First-line Therapy
    Schmale, Ine
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 (03) : 150 - 151
  • [43] NICE guidance on pazopanib for first-line treatment of advanced renal-cell carcinoma
    Griffiths, Christian
    Hay, Nicola
    Sutcliffe, Frances
    Stevens, Andrew
    LANCET ONCOLOGY, 2011, 12 (03): : 221 - 222
  • [44] Metastatic renal cell carcinoma: which treatments in first-line setting?
    Mery, Benoite
    Jones, Samuel
    Vallard, Alexis
    Rowinski, Elise
    Guillot, Aline
    Magne, Nicolas
    BULLETIN DU CANCER, 2018, 105 : S235 - S241
  • [45] Radical shifts in the first-line management of metastatic renal cell carcinoma
    Ornstein, Moshe C.
    Rini, Brian I.
    NATURE REVIEWS CLINICAL ONCOLOGY, 2019, 16 (02) : 71 - 72
  • [46] Radical shifts in the first-line management of metastatic renal cell carcinoma
    Moshe C. Ornstein
    Brian I. Rini
    Nature Reviews Clinical Oncology, 2019, 16 : 71 - 72
  • [47] First-Line Therapy of Metastatic Renal Cell Carcinoma - Update 2009
    Miller, Kurt
    ONKOLOGIE, 2010, 33 : 5 - 9
  • [48] Approaches to First-Line Therapy for Metastatic Clear Cell Renal Cell Carcinoma
    Yu-Wei Chen
    Brian I. Rini
    Current Oncology Reports, 2022, 24 : 695 - 702
  • [49] Approaches to First-Line Therapy for Metastatic Clear Cell Renal Cell Carcinoma
    Chen, Yu-Wei
    Rini, Brian, I
    CURRENT ONCOLOGY REPORTS, 2022, 24 (06) : 695 - 702
  • [50] Recent Advances in First-Line Management of Metastatic Renal Cell Carcinoma
    Dabkara, Deepak
    Biswas, Bivas
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2022, 43 (02) : 195 - 200
12345